Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now TSXV - Delayed Quote • CAD Devonian Health Group Inc. (GSD.V) Follow Add holdings 0.1800 0.0000 (0.00%) At close: April 7 at 9:48:03 AM EDT Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for GSD.V 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: GSD.V View More All News Press Releases SEC Filings Devonian Health Group Announces Reinstatement of Quotation on the TSXV Devonian Health Group Reports Second Quarter 2025 Financial Results Devonian Health Group Reports Cease Trade Order Devonian Health Group First Quarter 2025 Earnings: CA$0.004 loss per share (vs CA$0.005 loss in 1Q 2024) Devonian Reports Delay of Financial Reporting Devonian Reports Results of its Annual General and Special Meeting of Shareholders Devonian Announces the Filing of a New Patent Application Relating to the Use of Thykamine™ as an Antifibrotic Agent Devonian Announces Positive in Vivo Results of Thykamine™ on Gene Expression Associated With Fibrosis Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use of Thykamine™ for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH) Devonian Reports Positive Results in MASH Liver Study Devonian Reports Distribution Agreement Termination Related Tickers RKV.V Rakovina Therapeutics Inc. 0.0500 0.00% ICU SeaStar Medical Holding Corporation 1.2850 -1.15% ATNM Actinium Pharmaceuticals, Inc. 1.5500 +4.03% MRNA Moderna, Inc. 27.61 +2.15%